Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mannkind Corp (MNKD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 229,633
  • Shares Outstanding, K 140,020
  • Annual Sales, $ 11,750 K
  • Annual Income, $ -117,330 K
  • 36-Month Beta 2.82
  • Price/Sales 20.27
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.61 +1.55%
on 07/16/18
2.05 -20.24%
on 06/26/18
-0.26 (-13.95%)
since 06/15/18
3-Month
1.61 +1.55%
on 07/16/18
2.08 -21.39%
on 06/07/18
-0.04 (-2.68%)
since 04/17/18
52-Week
1.09 +50.69%
on 08/08/17
6.96 -76.51%
on 10/10/17
+0.28 (+21.11%)
since 07/17/17

Most Recent Stories

More News
Factors of Influence in 2018, Key Indicators and Opportunity within MannKind, Healthcare Services Group, Cadence, Superior Energy Services, National Presto Industries, and New Media Investment Group -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MannKind Corporation (NASDAQ:MNKD),...

CADE : 29.25 (+0.62%)
SPN : 9.63 (+1.26%)
NPK : 120.00 (unch)
NEWM : 18.46 (-0.75%)
MNKD : 1.63 (-0.61%)
HCSG : 42.88 (+0.37%)
MannKind Set to Join Russell 3000(R) Index

MannKind Corporation (Nasdaq:MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension,...

MNKD : 1.63 (-0.61%)
Implied Volatility Surging for MannKind Corporation (MNKD) Stock Options

Investors in MannKind (MNKD) need to pay close attention to the stock based on moves in the options market lately.

MNKD : 1.63 (-0.61%)
Additional Positive Afrezza(R) Clinical Data from STAT Study To Be Presented at ADA 78th Scientific Sessions

Oral presentation (348-OR) at 5:00 pm today

MNKD : 1.63 (-0.61%)
MannKind Presents Positive Afrezza(R) Clinical Data from STAT and AFFINITY Studies at ADA 78th Scientific Sessions

Poster 1017-P: Afrezza provides improved Time-in-Range on Continuous Glucose Monitoring compared to insulin aspart

MNKD : 1.63 (-0.61%)
MannKind to Host Institutional Investor and Analyst Meeting

Renowned Endocrinology Expert Presenting Current Trends in Treatment and Management of Diabetes

MNKD : 1.63 (-0.61%)
MannKind Successfully Completes Phase 1 Trial of Treprostinil Technosphere for Pulmonary Arterial Hypertension Advancing Development to Next Phase

-- Progressive dosing of Treprostinil Technosphere (TreT) significantly exceeded the corresponding peak plasma and exposure levels of the maximum recommended dose of Tyvaso(R) Inhalation Solution

MNKD : 1.63 (-0.61%)
MannKind Establishes Market Price Stock Purchase Plan

MannKind Corporation (NASDAQ:MNKD) has established a stock purchase plan that provides MannKind's directors and executive officers with a way to purchase shares of common stock directly from the Company...

MNKD : 1.63 (-0.61%)
Detailed Research: Economic Perspectives on Churchill Downs, Nordic American Tankers, News Corporation, Aduro Biotech, MannKind, and Crane -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Churchill Downs, Incorporated...

CHDN : 306.00 (+0.77%)
NAT : 2.39 (-1.65%)
NWS : 15.55 (-0.64%)
ADRO : 6.95 (+0.36%)
MNKD : 1.63 (-0.61%)
CR : 81.37 (+0.22%)
Is the Options Market Predicting a Spike in MannKind (MNKD) Stock?

Investors need to pay close attention to MannKind (MNKD) stock based on the movements in the options market lately.

MNKD : 1.63 (-0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade MNKD with:

Business Summary

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder...

See More

Key Turning Points

2nd Resistance Point 1.75
1st Resistance Point 1.70
Last Price 1.63
1st Support Level 1.60
2nd Support Level 1.55

See More

52-Week High 6.96
Fibonacci 61.8% 4.72
Fibonacci 50% 4.02
Fibonacci 38.2% 3.33
Last Price 1.63
52-Week Low 1.09

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar